Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to Konstantinos Arnaoutakis

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Arnaoutakis, Konstantinos

Item TypeName
Academic Article Lung cancer in octogenarians.
Concept Carcinoma, Non-Small-Cell Lung
Academic Article Gains of 2p23/ALK locus are common in non-small cell lung carcinoma: Clinical and molecular correlations
Academic Article Accuracy of fine needle aspiration and core lung biopsies to predict histology in patients with non-small cell lung cancer
Academic Article Accuracy of fine needle aspiration and core lung biopsies to predict histology in patients with non-small cell lung cancer.
Academic Article Crizotinib in ROS1-rearranged non-small-cell lung cancer.
Academic Article PARP1 Is Up-Regulated in Non-small Cell Lung Cancer Tissues in the Presence of the Cyanobacterial Toxin Microcystin.
Grant PHASE 3 Study EVAL EFFICACY AND SAFETY OF MPDL32 80A (IN COMBINATION W CARBOPLATIN+PACLITAXEL OR MPDL3280A IN COMBO W CARBO+NAB -PACLITAXEL VERSUS CARBO+NAB-PACLITAXEL IN CHEMO-NAÏVE PTS W STAGE 4 SQUAMOUS NON SMALL CELL LUNG CANCER
Grant Phase 2, Open-Label Single Arm Study of the Efficacy and Safety of PF-02341066 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Echino
Academic Article Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer-Transformed EGFR Mutant Non-Small-Cell Lung Cancer.
Grant LUNGMAP - A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study) (IRB 239473)
Grant S1900C: A Phase II Study of Talazoparib Plus Avelumab in Patients with Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer Bearing Pathogenic STK11 Genomic Alterations (LUNG-MAP Sub-Study) (260760)
Grant S1900B: A Phase II Study of LOXO-292 in Patients with RET Fusion-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study) (260759)

Search Criteria
  • Carcinoma Non Small Cell Lung